A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was whether port-access mitral valve repair reduces the recovery period of patients compared to the conventional sternotomy approach. Using the reported search, 778 papers were identified. Thirteen papers represented the best evidence on the subject and the author, journal, date and country of publication, patient group studied, study type, relevant outcomes, results and study comments and weaknesses were tabulated. The 13 papers demonstrated that patients who undergo minimally invasive mitral valve repair have a shorter ICU and total hospital stay than those who undergo the sternotomy approach. Results vary but mean hospital stays range from 5.6 to 13 days in port-access groups compared to 6.25-15 days in sternotomy groups. Other advantages over the sternotomy approach were reduced postoperative bleeding and pain, shorter time to extubation and a quicker return to daily activities. However, it is consistently reported that operative time is longer, with the increase in bypass time being around 30 min. We conclude that in several cohort studies minimally invasive mitral valve repair is reported to result in a shorter ICU and hospital stay, reduced postoperative bleeding and pain and a shorter time to resuming normal activities. This is at the expense of longer bypass and operative times.
Introduction
A best evidence topic was constructed according to a structured protocol, described in the ICVTS w1x.
Clinical scenario
You are a general practitioner who suffered from two episodes of paroxysmal atrial fibrillation. Having heard a pansystolic murmur on self-examination, you see a cardiologist who demonstrates moderate mitral regurgitation from a prolapsing P2 segment. You are aware of port-access mitral valve repair as an alternative to sternotomy but elect to search for the evidence that this approach is both safe and superior to the more conventional approach prior to being referred for surgery.
Three-part question
In wpatients requiring mitral valve repairx does wminimally invasive mitral valve repairx compared to wconventional repairx safely improve wclinical outcomesx? *Corresponding author. Tel.yfax: q44 7894 559594. E-mail address: l.e.richardson@bsms.ac.uk (L. Richardson).
Search strategy
Medline 1950 to March 2008 using OVID Interface. wexp mitral valve prolapseyOR exp mitral valve insufficiencyyOR exp heart valve prosthesis implantationyOR mitral repair.mpx AND wexp surgical proceduresyOR exp minimally invasiveyOR exp port-accessyOR exp heartportx. Embase 1980 to March 2008. wexp mitral valve prolapseyOR exp mitral valve insufficiencyx AND wexp minimally invasiveyOR exp port accessx. Cochrane Database of Systematic Reviews and the Cochrane Controlled Trials register searched on 1st March 2008 using search terms 'minimally invasive' and 'mitral valve repair'. References of resulting papers were also reviewed.
Search outcome
Four hundred and forty-five papers were found in Medline, 332 abstracts from Embase and one paper from the Cochrane controlled trials register. From these studies 13 represented the best evidence on the topic (Table 1) . We included seven cohort studies w2-8x, four of which were comparative and three that studied the peri-and postoperative outcomes of minimally invasive mitral valve surgery alone, four comparative case-control studies w9-12x and two prospective randomised studies w13, 14x. 
Comments
One of the two prospective randomised trials included only mitral valve repair operations, however, they recruited a small patient population w13x, therefore, further larger randomised trials are needed to consolidate their findings. The remaining studies are all uncontrolled comparative studies with their obvious limitations.
In nine studies w3, 4, 7 -13x, a minimally invasive approach was compared to the sternotomy approach. In all these studies, the mean ICU stay was shorter in patients who underwent minimally invasive mitral valve surgery ranging from 10 h w13x to 2.1 days w3x, compared to sternotomy patients which ranged from 1.6 w13x to 3.9 days w3x. In six of the comparative studies, the total hospital stay was shorter in the minimally invasive patient group ranging from 5.6 w4x to 13 days w10x, compared to sternotomy patients ranging from 6.25 w12x to 15 days w10x. As the patient groups in the majority of studies were small, these results were not statistically significant, however, they suggest that patients undergoing minimally invasive mitral valve repair will leave hospital earlier than sternotomy patients.
Other advantages of minimally invasive surgery were a shorter time to extubation with a difference of 18 h w3x, a statistically significant faster return to normal activity of 4 vs. 9 weeks w7x, a reduction in pain medication postoperatively w8x and a reduction in postoperative bleeding with a difference ranging from 449 w14x to 670 ml w11x between minimally invasive and sternotomy patients. Two studies did not compare to sternotomy, however, they did observe low mortality rates of 1.1% w5x and no peri-vascular leak on 3-month follow-up w6x.
Two of the comparative studies w3, 9x compared the sternotomy to robotic-assisted (da Vinci) minimally invasive surgery. Additionally, procedure variability was present; De Vaumas et al. w10x and Aklog et al. w4x performed a relatively long 8-10 cm incision with excision of the 3rd and 4th costal cartilages, while Yamada et al. w8x performed a mini-sternotomy. The difference in relative invasiveness of the surgeons may account for the ranges in results attained.
Casselman et al. w2x performed a retrospective study of 187 patients who underwent endoscopic mitral valve repair and distributed a patient satisfaction questionnaire at follow-up. It showed that 93.5% of patients experienced minimal pain and 33.7% had returned to routineywork activity within 4 weeks, with another 26.6% within 8 weeks.
A peri-operative outcome observed in seven of the nine comparative studies w3, 7-9, 13x was a longer time on bypass (min) in the minimally invasive group of 165.5 compared to 130.6 for sternotomy patients.
Clinical bottom line
Minimally invasive mitral valve repair shortens hospital and ICU stay compared to the sternotomy approach. Other postoperative benefits include less postoperative bleeding probably due to the avoidance of sternotomy, shorter time to extubation, less postoperative pain, shorter period of returning to normal activities and low hospital mortality. As the bypass period and anaesthetic set-up are longer, the operative time is longer than sternotomy. We read with interest this collective review of Lydia Richardson and coworkers w1x. The authors focused on whether port-access mitral valve repair reduces the recovery period of patients compared to the conventional sternotomy approach. The 13 papers representing the best evidence on the subject, demonstrated that patients who undergo minimally invasive mitral valve repair have a shorter ICU and total hospital stay than those who undergo the sternotomy approach. This in spite of the longer reported operative time and increase in bypass time being around 30 min.
The surgical experience of our group is of a total of 1734 minimally invasive cardiac surgical operations done either via a ministernotomy (921 patients) or a port access technique (813 patients) starting March 1997 to June 2007. We believe that a stronger evidence of advantages in terms of blood losses, complications and eventually hospital stay may be seen in redo cases. In this group of patients, minimally invasive surgery (via either ministernotomy or port access technique) has reduced operative times.
Re-do operation through a median sternotomy, with dissection of the adhesions is time-consuming. Reducing the width of the operative field, as in minimally invasive surgery, the total time of the operation is decreased and may be less than surgery performed by conventional sternotomy w2-4x.
